Research ArticleConference Proceedings

Medication Regimens for Managing Acute Asthma

Diego J Maselli and Jay I Peters
Respiratory Care June 2018, 63 (6) 783-796; DOI: https://doi.org/10.4187/respcare.05953

References

  1. 1.↵
    Global Initiative for Asthma (GINA). GINA Report, Global Strategy for Asthma Management and Prevention, 2017. http://www.ginasthma.org. Accessed on June 1, 2017.
  2. 2.↵
    1. Bateman ED,
    2. Boushey HA,
    3. Bousquet J,
    4. Busse WW,
    5. Clark TJ,
    6. Pauwels RA,
    7. Pedersen SE
    . Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170(8):836–844.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Wamboldt MZ,
    2. Bihun JT,
    3. Szefler S,
    4. Hewitt J
    . Perception of induced bronchoconstriction in a community sample of adolescents. J Allergy Clin Immunol 2000;106(6):1102–1107.
    OpenUrlPubMed
  4. 4.↵
    1. Magadle R,
    2. Berar-Yanay N,
    3. Weiner P
    . The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 2002;121(2):329–333.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Newman KB,
    2. Milne S,
    3. Hamilton C,
    4. Hall K
    . A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma. Chest 2002;121(4):1036–1041.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Rodrigo GJ,
    2. Rodrigo C
    . Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002;122(1):160–165.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Camargo CA Jr.,
    2. Spooner CH,
    3. Rowe BH
    . Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003;(4):CD001115.
  8. 8.↵
    1. Travers AH,
    2. Jones AP,
    3. Camargo CA Jr.,
    4. Milan SJ,
    5. Rowe BH
    . Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database Syst Rev 2012;12:CD010256.
    OpenUrlPubMed
  9. 9.↵
    1. Travers AH,
    2. Milan SJ,
    3. Jones AP,
    4. Camargo CA Jr.,
    5. Rowe BH
    . Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev 2012;12:CD010179.
    OpenUrlPubMed
  10. 10.↵
    1. Louridas G,
    2. Kakoura M,
    3. Galanis N,
    4. Patakas D,
    5. Kastritsi K
    . Bronchodilatory effect of inhaled versus oral salbutamol in bronchial asthma. Respiration 1983;44(6):439–443.
    OpenUrlPubMed
  11. 11.↵
    1. Rodrigo GJ,
    2. Castro-Rodriguez JA
    . Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005;60(9):740–746.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Kirkland SW,
    2. Vandenberghe C,
    3. Voaklander B,
    4. Nikel T,
    5. Campbell S,
    6. Rowe BH
    . Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma. Cochrane Database Syst Rev 2017;1:CD001284.
    OpenUrl
  13. 13.↵
    1. Griffiths B,
    2. Ducharme FM
    . Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2013;(8):CD000060.
  14. 14.↵
    1. Lahn M,
    2. Bijur P,
    3. Gallagher EJ
    . Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest 2004;126(2):362–368.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Hasegawa T,
    2. Ishihara K,
    3. Takakura S,
    4. Fujii H,
    5. Nishimura T,
    6. Okazaki M,
    7. et al
    . Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study. Intern Med 2000;39(10):794–797.
    OpenUrlPubMedWeb of Science
  16. 16.↵
    1. Jones AM,
    2. Munavvar M,
    3. Vail A,
    4. Aldridge RE,
    5. Hopkinson L,
    6. Rayner C,
    7. O'Driscoll BR
    . Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma. Respir Med 2002;96(11):950–954.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Rowe BH,
    2. Spooner CH,
    3. Ducharme FM,
    4. Bretzlaff JA,
    5. Bota GW
    . Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2007;(3):CD000195.
  18. 18.↵
    1. Kew KM,
    2. Quinn M,
    3. Quon BS,
    4. Ducharme FM
    . Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev 2016;(6):CD007524.
  19. 19.↵
    1. Edmonds ML,
    2. Milan SJ,
    3. Camargo CA Jr.,
    4. Pollack CV,
    5. Rowe BH
    . Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2012;12:CD002308.
    OpenUrl
  20. 20.↵
    1. Barnes PJ
    . Theophylline. Pharmaceuticals (Basel) 2010;3(3):725–747.
    OpenUrl
  21. 21.↵
    1. Nair P,
    2. Milan SJ,
    3. Rowe BH
    . Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev 2012;12:CD002742.
    OpenUrl
  22. 22.↵
    1. Kumasaka D,
    2. Lindeman KS,
    3. Clancy J,
    4. Lande B,
    5. Croxton TL,
    6. Hirshman CA
    . MgSO4 relaxes porcine airway smooth muscle by reducing Ca2+ entry. Am J Physiol 1996;270(3 Pt 1):L469–L474.
    OpenUrl
  23. 23.↵
    1. Gourgoulianis KI,
    2. Chatziparasidis G,
    3. Chatziefthimiou A,
    4. Molyvdas PA
    . Magnesium as a relaxing factor of airway smooth muscles. J Aerosol Med 2001;14(3):301–307.
    OpenUrlPubMed
  24. 24.↵
    1. Rowe BH,
    2. Bretzlaff JA,
    3. Bourdon C,
    4. Bota GW,
    5. Camargo CA Jr.
    . Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med 2000;36(3):181–190.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Bessmertny O,
    2. DiGregorio RV,
    3. Cohen H,
    4. Becker E,
    5. Looney D,
    6. Golden J,
    7. et al
    . A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults. Ann Emerg Med 2002;39(6):585–591.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Gallegos-Solórzano MC,
    2. Pérez-Padilla R,
    3. Hernández-Zenteno RJ
    . Usefulness of inhaled magnesium sulfate in the coadjuvant management of severe asthma crisis in an emergency department. Pulm Pharmacol Ther 2010;23(5):432–437.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Hughes R,
    2. Goldkorn A,
    3. Masoli M,
    4. Weatherall M,
    5. Burgess C,
    6. Beasley R
    . Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet 2003;361(9375):2114–2117.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Mahajan P,
    2. Haritos D,
    3. Rosenberg N,
    4. Thomas R
    . Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma. J Emerg Med 2004;27(1):21–25.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Goodacre S,
    2. Cohen J,
    3. Bradburn M,
    4. Gray A,
    5. Benger J,
    6. Coats T
    . Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial. Lancet Respir Med 2013;1(4):293–300.
    OpenUrl
  30. 30.↵
    1. Rodrigo GJ,
    2. Castro-Rodriguez JA
    . Heliox-driven β2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014;112(1):29–34.
    OpenUrl
  31. 31.↵
    1. Nutbeam T,
    2. Fergusson A
    . Towards evidence based emergency medicine: Best BETs from the Manchester Royal Infirmary. BET 2: Is endotracheal adrenaline useful in acute asthma? Emerg Med J 2009;26(6):435.
    OpenUrlFREE Full Text
  32. 32.↵
    1. Gibson PG,
    2. Powell H,
    3. Coughlan J,
    4. Wilson AJ,
    5. Abramson M,
    6. Haywood P,
    7. et al
    . Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003;(1):CD001117.
  33. 33.↵
    1. Carruthers DM,
    2. Harrison BD
    . Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax 1995;50(2):186–188.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Grunfeld A,
    2. FitzGerald J
    . Discharge considerations for adult asthmatics patients treated in emergency departments. Car Respir J 1996;3:322–327.
    OpenUrl
  35. 35.↵
    1. Bradding P,
    2. Rushby I,
    3. Scullion J,
    4. Morgan MD
    . As-required versus regular nebulized salbutamol for the treatment of acute severe asthma. Eur Respir J 1999;13(2):290–294.
    OpenUrlAbstract
  36. 36.↵
    1. Chien JW,
    2. Ciufo R,
    3. Novak R,
    4. Skowronski M,
    5. Nelson J,
    6. Coreno A,
    7. McFadden ER Jr.
    . Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000;117(3):728–733.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.
    1. Rodrigo GJ,
    2. Rodriquez Verde M,
    3. Peregalli V,
    4. Rodrigo C
    . Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003;124(4):1312–1317.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Perrin K,
    2. Wijesinghe M,
    3. Healy B,
    4. Wadsworth K,
    5. Bowditch R,
    6. Bibby S,
    7. et al
    . Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax 2011;66(11):937–941.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Brophy C,
    2. Ahmed B,
    3. Bayston S,
    4. Arnold A,
    5. McGivern D,
    6. Greenstone M
    . How long should Atrovent be given in acute asthma? Thorax 1998;53(5):363–367.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Lederle FA,
    2. Pluhar RE,
    3. Joseph AM,
    4. Niewoehner DE
    . Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial. Arch Intern Med. 1987;147(12):2201–2203.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. O'Driscoll BR,
    2. Kalra S,
    3. Wilson M,
    4. Pickering CA,
    5. Carroll KB,
    6. Woodcock AA
    . Double-blind trial of steroid tapering in acute asthma. Lancet. 1993;341(8841):324–327.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Darioli R,
    2. Perret C
    . Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984;129(3):385–387.
    OpenUrlPubMedWeb of Science
  43. 43.↵
    1. Menitove SM,
    2. Goldring RM
    . Combined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med 1983;74(5):898–901.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Tuxen DV,
    2. Lane S
    . The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis 1987;136(4):872–879.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Peters JI,
    2. Stupka JE,
    3. Singh H,
    4. Rossrucker J,
    5. Angel LF,
    6. Melo J,
    7. Levine SM
    . Status asthmaticus in the medical intensive care unit: A 30-year experience. Respir Med 2012;106(3):344–348.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Kelly HW
    . New beta 2-agonist aerosols. Clin Pharm Ther 1985;4(4):393–403.
    OpenUrl
  47. 47.↵
    1. MacIntyre NR,
    2. Silver RM,
    3. Miller CW,
    4. Schuler F,
    5. Coleman RE
    . Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985;13(2):81–84.
    OpenUrlPubMedWeb of Science
  48. 48.↵
    1. Haskell RJ,
    2. Wong BM,
    3. Hansen JE
    . A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med 1983;143(7):1324–1327.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Lim WJ,
    2. Mohammed Akram R,
    3. Carson KV,
    4. Mysore S,
    5. Labiszewski NA,
    6. Wedzicha JA,
    7. et al
    . Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2012;12:CD004360.
    OpenUrlPubMed
  50. 50.↵
    1. Soroksky A,
    2. Stav D,
    3. Shpirer I
    . A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003;123(4):1018–1025.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Gupta D,
    2. Nath A,
    3. Agarwal R,
    4. Behera D
    . A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma. Respir Care 2010;55(5):536–543.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. Murase K,
    2. Tomii K,
    3. Chin K,
    4. Tsuboi T,
    5. Sakurai A,
    6. Tachikawa R,
    7. Harada Y,
    8. Takeshima Y,
    9. Hayashi M,
    10. Ishihara K
    . The use of non-invasive ventilation for life-threatening asthma attacks: Changes in the need for intubation. Respirology. 2010;15(4):714–720.
    OpenUrlPubMed
  53. 53.↵
    1. Alves D,
    2. Freitas AS,
    3. Jacinto T,
    4. Vaz MS,
    5. Lopes FO,
    6. Fonseca JA
    . Increasing use of non-invasive ventilation in asthma: a long-term analysis of the Portuguese national hospitalization database. J Asthma. 2014;51(10):1068–1075.
    OpenUrlPubMed
  54. 54.↵
    1. Camargo CA Jr.,
    2. Gurner DM,
    3. Smithline HA,
    4. Chapela R,
    5. Fabbri LM,
    6. Green SA,
    7. et al
    . A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010;125(2):374–380.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Appel D,
    2. Karpel JP,
    3. Sherman M
    . Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate. J Allergy Clin Immunol 1989;84(1):90–98.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    1. Takahashi S,
    2. Uemura A,
    3. Nakayama S,
    4. Miyabe M,
    5. Toyooka H
    . Bronchospasms and wheezing after induction of anesthesia with propofol in patients with a history of asthma. J Anesth 2002;16(4):360–361.
    OpenUrlPubMed
  57. 57.↵
    1. Stemp LI
    . Ketamine for status asthmaticus with respiratory failure. J Emerg Med 2014;47(5):571–572.
    OpenUrl
  58. 58.↵
    1. Mikkelsen ME,
    2. Pugh ME,
    3. Hansen-Flaschen JH,
    4. Woo YJ,
    5. Sager JS
    . Emergency extracorporeal life support for asphyxic status asthmaticus. Respir Care 2007;52(11):1525–1529.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    1. Di Lascio G,
    2. Prifti E,
    3. Messai E,
    4. Peris A,
    5. Harmelin G,
    6. Xhaxho R,
    7. Fico A,
    8. Sani G,
    9. Bonacchi M
    . Extracorporeal membrane oxygenation support for life-threatening acute severe status asthmaticus. Perfusion. 2017;32(2):157–163.
    OpenUrl
  60. 60.↵
    1. Yeo HJ,
    2. Kim D,
    3. Jeon D,
    4. Kim YS,
    5. Rycus P,
    6. Cho WH
    . Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry. Crit Care 2017;21(1):297.
    OpenUrl
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords